Equities

Citrine Global Corp

CTGL:PKL

Citrine Global Corp

Actions
  • Price (USD)0.0095
  • Today's Change0.00 / 0.00%
  • Shares traded500.00
  • 1 Year change-76.25%
  • Beta0.3502
Data delayed at least 15 minutes, as of Jun 21 2024 19:49 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Citrine Global Corp, formerly knows as Techcare Corp., is an Israeli-based company. The Company is engaged is an operational, asset and real estate finance, and consultancy in value creation and implementation strategy for technology companies. Citrine Global focuses on these industries such as health, wellness, food tech and medical cannabis.

  • Revenue in USD (TTM)0.00
  • Net income in USD-2.38m
  • Incorporated2010
  • Employees18.00
  • Location
    Citrine Global Corp11Th Floor 3 Hamelacha StTEL AVIV-YAFO 6721503IsraelISR
  • Phone+1 3 027770210
  • Fax+1 3 026583694
  • Websitehttps://www.citrine-global.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Bionoid Pharma Inc0.001.35m5.40m13.000.0882--3.99--1.131.130.00-0.1744-----------506.64--------------327.24---------31.55--26.01--
Guided Therapeutics Inc82.00k-3.23m5.62m4.00------68.59-0.0623-0.06230.0016-0.07210.03740.090411.7120,500.00-137.80-136.13----32.9329.39-3,685.37-3,666.670.1138-11.13----653.8511.4524.40------
VirExit Technologies Inc0.00-1.80m6.05m-----------0.0932-0.1130.00-0.03670.00-------6,103.43-----------------3.66-----100.00--19.08------
Sonendo Inc40.19m-57.74m6.16m216.00--0.2513--0.1534-0.6125-0.55520.4260.34820.44482.077.58186,055.60-63.91---78.82--27.64---143.67--2.14-10.830.4695--5.30---6.78------
Sigyn Therapeutics Inc0.00-3.56m6.43m5.00---------3.04-3.040.00-3.280.00----0.00-724.37-493.15-----------10,223.960.0199-1.92---------41.51------
Vivos Therapeutics Inc13.36m-15.64m7.20m114.00--10.47--0.5386-11.00-11.008.730.21310.9247--31.59117,219.30-108.24-89.72-243.30-149.7058.9070.20-117.06-113.15----0.00---13.8729.4843.04---8.48--
Neurometrix Inc5.27m-7.98m7.46m26.00--0.393--1.42-6.32-6.324.209.440.23811.2510.08202,700.40-36.07-23.24-38.94-27.2661.9759.17-151.51-48.8810.11--0.00---28.52-18.18-47.84--5.03--
Biomerica Inc5.41m-6.35m7.54m62.00--0.9658--1.40-0.3789-0.37890.32240.46420.58272.285.7487,180.80-68.45-43.55-83.73-50.3211.4115.75-117.46-55.863.37--0.00---71.71-0.8229-57.58---9.76--
PAVmed Inc3.02m-71.05m7.82m107.00------2.59-9.08-9.080.3874-7.760.0588--64.1728,186.92-147.38-154.56---1,152.82-126.09---2,505.37-8,764.890.5301-8.321.82--550.40--25.76--55.51--
Innovative Eyewear Inc1.39m-7.20m8.46m11.00--1.22--6.08-0.6074-0.60740.11740.29480.28031.8915.42126,457.30-145.15---168.75---8.82---517.88--3.68-6,764.710.00--74.67---17.28------
Citrine Global Corp0.00-2.38m9.17m18.00---------0.0025-0.00250.00-0.00280.00----0.00-173.12-298.98---964.26-------4,814.84---5.41--------41.43---5.44--
PetVivo Holdings Inc1.05m-10.63m9.24m25.00--9.03--8.83-0.8694-0.86940.08420.060.33751.212.0441,841.60-343.12-209.90-715.73-504.6451.4120.27-1,016.55-2,297.210.6169-2,268.840.1392--693.46260.32-73.83--51.73--
ALR Technologies Inc9.49k-8.00m9.53m6.00------1,004.43-0.0147-0.01470.00002-0.04760.0358----1,581.67-3,015.28-12,861.64----62.49---84,283.24-406,011.30---0.8626---------42.72------
Biotricity Inc11.63m-15.39m10.86m55.00------0.9344-1.75-1.751.32-2.841.922.016.55211,408.70-240.40-303.46----65.5253.00-125.43-368.780.1012-0.5855----26.00--35.36------
STRATA Skin Sciences Inc32.55m-11.36m11.04m99.00--1.17--0.3394-3.25-3.259.312.690.733.678.60328,737.40-25.49-11.48-35.77-16.5552.7161.28-34.91-17.700.8376-3.900.6151---7.752.24-95.17--23.29--
Nexalin Technology Inc158.86k-4.94m12.20m6.00--5.24--76.77-0.6676-0.66760.02150.31290.03630.177844.0126,476.67-112.76---139.94--82.54---3,110.58--4.75--0.00---91.62---173.80------
Data as of Jun 21 2024. Currency figures normalised to Citrine Global Corp's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.